As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Research with Impact
Below are the top-cited articles from the last couple of years covering topics ranging from microRNAs to therapeutics to tumorigenesis. We are grateful to our authors for publishing such excellent and impactful research in our journal.
miR-378 suppresses the proliferation, migration, and invasion of colon cancer cells by inhibiting SDAD1
Mingxi Zeng, Linlin Zhu, Liangping Li, & Changming Kang
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Zakir Khan, Abdul Arif Khan, Hariom Yadav, Godavarthi B. K. S. Prasad, & Prakash Singh Bisen
Crosstalk between the Warburg effect, redox regulation, and autophagy induction in tumourigenesis
Mokgadi Violet Gwangwa, Anna Margaretha Joubert, & Michelle Helen Visagie
STAT3, stem cells, cancer stem cells and p63
Michaela Galoczova, Philip Coates, & Borivoj Vojtesek
-
-
Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1
-
The usefulness of lactate dehydrogenase measurements in current oncological practice
-
LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis
-
Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5
-
p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation
-
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach
-
Latent viruses can cause disease by disrupting the competition for the limiting factor p300/CBP
-
Cells of human breast milk
-
Osteoporosis: the current status of mesenchymal stem cell-based therapy
Aims and scope
Cellular & Molecular Biology Letters is an international journal dedicated to the dissemination of fundamental knowledge in all areas of cellular and molecular biology, cancer cell biology, and certain aspects of biochemistry, biophysics and biotechnology.
Editor-in-Chief
Aleksander Sikorski, University of Wrocław, Poland
Reviewer Acknowledgements
Please visit the Cellular and Molecular Biology Letters society website and click on "Acknowledgements to Referees" and the year you wish to search to view current and past reviewers
Archival content
Cellular & Molecular Biology Letters was founded in 1996 and transferred to BioMed Central in 2016. Previously, its publishers were Walter De Gruyter in 2015 (content available from De Gruyter's archive), and Springer from 2006–2014 (content available from BMC web page). Articles published between 1996 and 2005 can be found at the CMBL home page, on the Volume List tab. To request free electronic versions of these articles, please contact cmbl@cmbl.org.pl.
Follow
Affiliated with
Annual Journal Metrics
-
Speed
54 days to first decision for reviewed manuscripts only
26 days to first decision for all manuscripts
143 days from submission to acceptance
29 days from acceptance to publication
Citation Impact
3.451 - 2-year Impact Factor
2.892 - 5-year Impact Factor
0.940 - Source Normalized Impact per Paper (SNIP)
1.089 - SCImago Journal Rank (SJR)
Usage
166,007 downloads
108 Altmetric mentions
